ID

38609

Description

Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00768755

Lien

https://clinicaltrials.gov/show/NCT00768755

Mots-clés

Versions (1)
  1. 28/10/2019 28/10/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

28 octobre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Carcinoma, Non-Small Cell Lung NCT00768755

Anglais

Eligibility Carcinoma, Non-Small Cell Lung NCT00768755

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed diagnosis of adeno-, large cell or bronchioalveolar non-small cell lung cancer
Description

Adenocarcinoma of lung | Large cell carcinoma of lung | Bronchioloalveolar Non-Small Cell Lung Carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0152013
UMLS CUI [2]
C0345958
UMLS CUI [3,1]
C0007120
UMLS CUI [3,2]
C0007131
cytologic specimens for diagnosis or for cell type classification must have been obtained from bronchial brushings or washings or from needle aspiration of a defined lesion. sputum cytology alone will not be acceptable for diagnosis or for cell type classification.
Description

Cytologic material Cell type Classification | Bronchial brush biopsy | Bronchial washing | Lesion Fine needle aspiration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0225355
UMLS CUI [1,2]
C0449475
UMLS CUI [1,3]
C0008902
UMLS CUI [2]
C2370811
UMLS CUI [3]
C0396473
UMLS CUI [4,1]
C0221198
UMLS CUI [4,2]
C1510483
patients with mixed nsclc with predominantly squamous cell carcinoma should be classified as squamous and thus do not qualify for this study.
Description

Non-Small Cell Lung Carcinoma Mixed Ineligible | Squamous non-small cell lung cancer Ineligible

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205430
UMLS CUI [1,3]
C1512714
UMLS CUI [2,1]
C4509816
UMLS CUI [2,2]
C1512714
stage iiib with malignant effusion (with cytologic confirmation of malignant pleural or pericardial effusion), stage iv, or recurrent disease after definitive loco-regional therapy.
Description

TNM clinical staging | Pleural Effusion, Malignant | Malignant pericardial effusion | Recurrent disease | Status post Therapy Locoregional

Type de données

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C0080032
UMLS CUI [3]
C0220655
UMLS CUI [4]
C0277556
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0087111
UMLS CUI [5,3]
C1947913
candidate for primary treatment with cisplatin and pemetrexed
Description

Patient Appropriate Primary treatment | Cisplatin | pemetrexed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C1708063
UMLS CUI [2]
C0008838
UMLS CUI [3]
C0210657
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any histological/cytological evidence of predominantly squamous nsclc.
Description

Squamous non-small cell lung cancer predominant

Type de données

boolean

Alias
UMLS CUI [1,1]
C4509816
UMLS CUI [1,2]
C1542147
small cell or carcinoid lung cancer patients are also ineligible.
Description

Small cell carcinoma of lung | Carcinoid tumor of lung

Type de données

boolean

Alias
UMLS CUI [1]
C0149925
UMLS CUI [2]
C0280089
nsclc that cannot be classified as one of the eligible histologies (adenocarcinoma, large cell or bronchioalveolar).
Description

Non-Small Cell Lung Carcinoma Without Histology Eligible

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C4048239
UMLS CUI [1,4]
C1548635
prior systemic therapy for stage iiib (with malignant effusion), stage iv, or recurrent nsclc. (prior treatment with systemic therapy as adjuvant chemotherapy or in conjunction with radiotherapy for stage ii or iii nsclc is permitted if the last dose of chemotherapy was completed 12 months or more prior to randomization).
Description

Systemic therapy TNM clinical staging | Systemic therapy Malignant Effusion | Systemic therapy Non-small cell lung cancer recurrent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1515119
UMLS CUI [2,2]
C0080032
UMLS CUI [3,1]
C1515119
UMLS CUI [3,2]
C0278517
prior treatment with a vegf or vegfr inhibitor.
Description

VEGF Inhibitor | VEGFR Inhibitor

Type de données

boolean

Alias
UMLS CUI [1]
C4521299
UMLS CUI [2]
C2985521
Retour au début de la page

Similar models

Eligibility Carcinoma, Non-Small Cell Lung NCT00768755

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of lung | Large cell carcinoma of lung | Bronchioloalveolar Non-Small Cell Lung Carcinoma
Item
histologically or cytologically confirmed diagnosis of adeno-, large cell or bronchioalveolar non-small cell lung cancer
boolean
C0152013 (UMLS CUI [1])
C0345958 (UMLS CUI [2])
C0007120 (UMLS CUI [3,1])
C0007131 (UMLS CUI [3,2])
Cytologic material Cell type Classification | Bronchial brush biopsy | Bronchial washing | Lesion Fine needle aspiration
Item
cytologic specimens for diagnosis or for cell type classification must have been obtained from bronchial brushings or washings or from needle aspiration of a defined lesion. sputum cytology alone will not be acceptable for diagnosis or for cell type classification.
boolean
C0225355 (UMLS CUI [1,1])
C0449475 (UMLS CUI [1,2])
C0008902 (UMLS CUI [1,3])
C2370811 (UMLS CUI [2])
C0396473 (UMLS CUI [3])
C0221198 (UMLS CUI [4,1])
C1510483 (UMLS CUI [4,2])
Non-Small Cell Lung Carcinoma Mixed Ineligible | Squamous non-small cell lung cancer Ineligible
Item
patients with mixed nsclc with predominantly squamous cell carcinoma should be classified as squamous and thus do not qualify for this study.
boolean
C0007131 (UMLS CUI [1,1])
C0205430 (UMLS CUI [1,2])
C1512714 (UMLS CUI [1,3])
C4509816 (UMLS CUI [2,1])
C1512714 (UMLS CUI [2,2])
TNM clinical staging | Pleural Effusion, Malignant | Malignant pericardial effusion | Recurrent disease | Status post Therapy Locoregional
Item
stage iiib with malignant effusion (with cytologic confirmation of malignant pleural or pericardial effusion), stage iv, or recurrent disease after definitive loco-regional therapy.
boolean
C3258246 (UMLS CUI [1])
C0080032 (UMLS CUI [2])
C0220655 (UMLS CUI [3])
C0277556 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C1947913 (UMLS CUI [5,3])
Patient Appropriate Primary treatment | Cisplatin | pemetrexed
Item
candidate for primary treatment with cisplatin and pemetrexed
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C1708063 (UMLS CUI [1,3])
C0008838 (UMLS CUI [2])
C0210657 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Squamous non-small cell lung cancer predominant
Item
any histological/cytological evidence of predominantly squamous nsclc.
boolean
C4509816 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Small cell carcinoma of lung | Carcinoid tumor of lung
Item
small cell or carcinoid lung cancer patients are also ineligible.
boolean
C0149925 (UMLS CUI [1])
C0280089 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Without Histology Eligible
Item
nsclc that cannot be classified as one of the eligible histologies (adenocarcinoma, large cell or bronchioalveolar).
boolean
C0007131 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C4048239 (UMLS CUI [1,3])
C1548635 (UMLS CUI [1,4])
Systemic therapy TNM clinical staging | Systemic therapy Malignant Effusion | Systemic therapy Non-small cell lung cancer recurrent
Item
prior systemic therapy for stage iiib (with malignant effusion), stage iv, or recurrent nsclc. (prior treatment with systemic therapy as adjuvant chemotherapy or in conjunction with radiotherapy for stage ii or iii nsclc is permitted if the last dose of chemotherapy was completed 12 months or more prior to randomization).
boolean
C1515119 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C0080032 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3,1])
C0278517 (UMLS CUI [3,2])
VEGF Inhibitor | VEGFR Inhibitor
Item
prior treatment with a vegf or vegfr inhibitor.
boolean
C4521299 (UMLS CUI [1])
C2985521 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial